ORBIMED ADVISORS LLC

Q3 2024 13F-HR Holdings

Location
New York, NY
Holdings as of
9/30/2024
Date filed
11/14/2024
Form type
13F-HR
Num holdings
118
Total value ($000)
$5,503,519
Net value change ($000)
+438,993 (8.7%)
New positions
19
Sold out positions
18
Turnover %
9.9%
Sector allocation + QoQ delta (equities-only)

Holdings aggregated across other managers listed in the original SEC filing. View detailed breakdown

Prev filing: 8/14/2024 Next filing: 2/14/2025 SEC filing

Snapshot: Change Analysis

Compared to Q2 2024
Methodology: sector metrics are equities-only; instrument mix chart is ex-options; options exposure is shown separately. Why this matters.
Top Adds (Value $000, Stocks/ETFs)
EWTX 130,389 48.2%
MBX 99,041 NEW
QTTB 60,087 148.6%
UNH 47,621 83.5%
SPRY 41,543 52.8%
AMGN 39,144 92.9%
UHS 35,726 NEW
ITGR 34,314 84.9%
SYK 32,891 35.9%
BIOA 29,608 NEW
Top Reduces (Value $000, Stocks/ETFs)
JANX -67,648 -54.2%
BIIB -51,255 -24.5%
VRNA -41,382 -100.0%
GERN -37,864 -100.0%
ELV -35,863 -39.4%
DXCM -32,869 -100.0%
NBIX -26,882 -43.6%
THC -26,116 -16.7%
HRTX -22,795 -100.0%
MORPHIC HLDG INC -20,868 -100.0%
Instrument mix + QoQ Δ (ex-options)
Derivatives reported exposure ($000): 38,623 (0.7% of total reported value)
How this table is calculated: SEC VALUE ($000) is used as reported. For derivatives (PUT/CALL/WARRANT/RIGHT), SEC value represents reported underlying exposure, not premium cash paid/received. Column % is bucket-based: non-options share is calculated inside non-option total, options share is calculated inside options total. Details.
Filter:
Instrument:
Issuer Name Ticker Sector Industry Class History Value ($000) % Shares Shares Δ Shares Δ% Value Δ ($000) Value Δ% Principal Option Type